"Epidemiology "
"Clinical presentation "
"T1: involvement of the meninges may be more pronounced in the cerebellar folia and the basal cisterns"
"T2/FLAIR/DWI: focal or diffuse hyperintensities within the thalami, basal ganglia, cerebellum and anterior horns of the spinal cord"
"Tick-borne encephalitis virus is in the mammalian tick-borne flavivirus group of Flaviviridae, which are single-stranded RNA viruses. There are three subtypes of tick-borne encephalitis viruses - European, Siberian, and Far Eastern - the most virulent being the Far Eastern subtype 2."
Expected headings
"Epidemiology "
"Clinical presentation "
"pyrexia, myalgia, headache, fatigue and vomiting"
"T2/FLAIR/DWI: focal or diffuse hyperintensities within the thalami, basal ganglia, cerebellum and anterior horns of the spinal cord"
"range of potential clinical features, e.g. altered conscious state, ataxia, dysphasia, movement disorders (e.g. tongue tremor), cranial neuropathy, seizures"
"Tick-borne encephalitis virus is in the mammalian tick-borne flavivirus group of Flaviviridae, which are single-stranded RNA viruses. There are three subtypes of tick-borne encephalitis viruses - European, Siberian, and Far Eastern - the most virulent being the Far Eastern subtype 2."
"There is no treatment for tick-borne encephalitis and vaccination is encouraged. Although the risk of death is small (~1% 9), long term neurological sequelae - mainly gait disturbance - occur in approximately half of patients and may persist for several years 6."